SCoV-2 Ag Detect™ Rapid Self-Test, Now Available!

 
 

Reszon Diagnostics International to Manufacture Chembio’s HIV 1/2 STAT-PAK® Assay at Chembio Diagnostics Malaysia Facility

 
 

Launching Status COVID-19/Flu 15 Minute Visual Read Rapid Test in the USA

 
 

Launching DPP® SARS-CoV-2 Antigen System in Brazil

 
 

Introducing DPP HIV-Syphilis: The First & Only FDA Approved HIV-Syphilis Rapid Test

1
1

Contact your local Chembio Representative to learn more about our Status & Detect tests.

Stay up to date with our latest news.

Chembio Employees Working in the Lab
Chembio

Chembio Diagnostics Announces Agreement for Reszon Diagnostics International to Manufacture Chembio’s HIV 1/2 STAT-PAK Assay at Chembio Diagnostics Malaysia Facility

HAUPPAUGE, N.Y. , May 17, 2022 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Chembio) (Nasdaq: CEMI),…
COVID-19 Nasal Swab Test Image
Chembio

Chembio Announces EUA Submission for DPP Respiratory Antigen Panel: Test Provides Simultaneous Detection of Flu A, Flu B, and SARS-CoV-2

HAUPPAUGE, N.Y., Sept. 22, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care…
Chembio Launches Commercial Distribution of Third-Party COVID-19 Antigen Assay
Chembio

Chembio Launches Commercial Distribution of Third-Party COVID-19 Antigen Assay

HAUPPAUGE, N.Y., Aug. 27, 2021 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI), a leading point-of-care…
About Us

We enable longer and healthier living through detection and monitoring of infectious diseases at the point of care.

Our mission is to be a leader in the development, manufacturing and commercialization of diagnostic solutions. We are dedicated to delivering exceptional point-of-care products that are easy to use, fast and accurate.

Our Core Values: “RAPID”

Relentless

Accountable

Passionate

Innovative

Diverse

Learn More
Investor Relations

Chembio is a leading point of care diagnostics company focused on detecting and diagnosing infectious diseases.

Our patented DPP® technology platform uses a small drop of blood from the fingertip and provides high-quality, cost-effective results in 15-20 minutes. Our products are sold globally, directly and through distributors, to hospitals, clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers.

LEARN MORE
Chembio Testing

We are looking for talented, dedicated people wishing to contribute to our common vision of enhancing the health and well being of people worldwide.